Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trial.

导出 LinkOut

翻译打印收藏纠错

第一作者： Mehmet,Altan

第一单位： Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

作者： Mehmet,Altan ^[1] ; Yan,Wang ^[2] ; Juhee,Song ^[3] ; James,Welsh ^[2] ; Chad,Tang ^[2] ; Nandita,Guha-Thakurta ^[4] ; George R,Blumenschein ^[1] ; Brett W,Carter ^[5] ; Jeffrey S,Wefel ^[6] ; Amol J,Ghia ^[2] ; Debra N,Yeboa ^[2] ; Mary Frances,McAleer ^[2] ; Caroline,Chung ^[2] ; Kristina D,Woodhouse ^[2] ; Susan L,McGovern ^[2] ; Chenyang,Wang ^[2] ; Betty Y S,Kim ^[7] ; Jeffrey S,Weinberg ^[7] ; Tina M,Briere ^[8] ; Yasir Y,Elamin ^[1] ; Xiuning,Le ^[1] ; Tina,Cascone ^[1] ; Marcelo V,Negrao ^[1] ; Ferdinandos,Skoulidis ^[1] ; Renata,Ferrarotto ^[1] ; John V,Heymach ^[1] ; Jing,Li ^[9]

作者单位： Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ^[1] Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ^[2] Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ^[3] Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ^[4] Department of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ^[5] Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ^[6] Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ^[7] Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ^[8] Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA jing.li@mdanderson.org. ^[9]

关键词 Immune Checkpoint Inhibitors Non-Small Cell Lung Cancer Radiotherapy

主题词人类(Humans);脑肿瘤(Brain Neoplasms);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);肺肿瘤(Lung Neoplasms);放射外科手术(Radiosurgery);综合疗法(Combined Modality Therapy)

DOI 10.1136/jitc-2023-006871

PMID 37402581

发布时间 2024-09-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal for immunotherapy of cancer

2023年11卷7期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trial.

Journal for immunotherapy of cancer

相似文献

Journal for immunotherapy of cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trial.

Journal for immunotherapy of cancer

相似文献

Journal for immunotherapy of cancer

相关期刊

检索历史清除